The Human Cloning Policy Institute (HCPI) launched this week a major grassroots effort to head off a proposed ban on therapeutic cloning in the United Nations scheduled for vote this Thursday. The total ban is sponsored by Costa Rica and is supported by the United States. The Human Cloning Policy Institute is backed by Ian Wilmut (Dolly’s cloner), some of the world’s leading scientists, physicians and international law experts, including retired World Court judge, C.G. Weeramantry.
HCPI executive director, Bernard Siegel stated, “It is the widespread belief of leading scientists and medical researchers that failure to proceed with SCNT stem cell research is the equivalent to turning our backs on one of the greatest potential medical advances of our time and would thereby destroy the hope for understanding and treatment of many deadly diseases and conditions. A consequence of banning SCNT research might be to condemn millions of adults and children to premature death or a life of intense misery and suffering.”
HCPI has urged its supporters and allied organizations, including disease advocates, private citizens, members of biotechnology organizations, physicians, lawyers and members of the scientific research community, to support passage of UN initiatives outlawing human reproductive cloning, but which allow for the promise of SCNT. It opposes the Costa Rican proposed convention, which bans SCNT research and urges support for the rival Belgium compromise convention, which encourages member states to ban reproductive cloning, but would not ban SCNT internationally.
Bernard Siegel | alfa
Diabetes mellitus: A risk factor for early colorectal cancer
27.05.2020 | Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg
Ultra-thin fibres designed to protect nerves after brain surgery
27.05.2020 | Martin-Luther-Universität Halle-Wittenberg
In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".
Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...
Early detection of tumors is extremely important in treating cancer. A new technique developed by researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The work is published May 25 in the journal Nature Nanotechnology.
researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from...
Microelectronics as a key technology enables numerous innovations in the field of intelligent medical technology. The Fraunhofer Institute for Biomedical Engineering IBMT coordinates the BMBF cooperative project "I-call" realizing the first electronic system for ultrasound-based, safe and interference-resistant data transmission between implants in the human body.
When microelectronic systems are used for medical applications, they have to meet high requirements in terms of biocompatibility, reliability, energy...
Thomas Heine, Professor of Theoretical Chemistry at TU Dresden, together with his team, first predicted a topological 2D polymer in 2019. Only one year later, an international team led by Italian researchers was able to synthesize these materials and experimentally prove their topological properties. For the renowned journal Nature Materials, this was the occasion to invite Thomas Heine to a News and Views article, which was published this week. Under the title "Making 2D Topological Polymers a reality" Prof. Heine describes how his theory became a reality.
Ultrathin materials are extremely interesting as building blocks for next generation nano electronic devices, as it is much easier to make circuits and other...
Scientists took a leukocyte as the blueprint and developed a microrobot that has the size, shape and moving capabilities of a white blood cell. Simulating a blood vessel in a laboratory setting, they succeeded in magnetically navigating the ball-shaped microroller through this dynamic and dense environment. The drug-delivery vehicle withstood the simulated blood flow, pushing the developments in targeted drug delivery a step further: inside the body, there is no better access route to all tissues and organs than the circulatory system. A robot that could actually travel through this finely woven web would revolutionize the minimally-invasive treatment of illnesses.
A team of scientists from the Max Planck Institute for Intelligent Systems (MPI-IS) in Stuttgart invented a tiny microrobot that resembles a white blood cell...
19.05.2020 | Event News
07.04.2020 | Event News
06.04.2020 | Event News
29.05.2020 | Life Sciences
29.05.2020 | Physics and Astronomy
29.05.2020 | Life Sciences